Clinical Trial: Channa Striatus Extract on Albumin and Hs-CRP ESRD
Study Status: Completed
Recruit Status: Completed
Condition:
End-Stage Renal Disease
Inflammation
Study Type: Interventional
Official Title: The Effect of Channa Striatus Extract on Serum Albumin and High Sensitive C-Reactive Protein in End-Stage Renal Disease Patients
Brief Summary:
This study is a randomised, double blind, placebo-controlled study in patients with ESRD on HD or CAPD based RRTs at Moewardi General Hospital in Surakarta, Indonesia from January to March 2021. Subjects were randomized to either a Channa striata or a placebo group and were given a three times daily dosage of 500 mg of Channa striatus extract or 500 mg maltodextrin, respectively for 21 days. Serum albumin and hs-CRP were measured at the baseline, and at the end of the study
Read more